Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02607033 · ClinicalTrials.gov registry record · NA

Exercise and Weight Loss in PAD

A NA study of Peripheral Arterial Disease, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT02607033 is a NA study of Peripheral Arterial Disease that has completed, run by VA Office of Research and Development. The registered enrollment target is 18 participants, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02607033, a NA study of Peripheral Arterial Disease, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

This study is designed to examine the added benefits of weight loss to an exercise program in older obese Veterans with peripheral arterial disease. The investigators want to determine if weight loss in addition to exercise will 1) improve walking ability to a greater extent than exercise alone and 2) determine the underlying reasons why walking ability improves by measuring blood flow and the amount of muscle in the leg muscles.

Interventions

  • OTHER Exercise
  • OTHER Weight Loss

Study Locations (1)

Maryland

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD - Baltimore

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2015-10-01
Est. Completion 2023-02-01
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT02607033

The ClinicalTrials.gov registry entry for NCT02607033 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (100% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.

NCT02607033 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT02607033 about?

NCT02607033 is a clinical study titled "Exercise and Weight Loss in PAD". This study is designed to examine the added benefits of weight loss to an exercise program in older obese Veterans with peripheral arterial disease. The investigators want to determine if weight loss in addition to exercise will 1) improve walking ability to a greater extent than exercise alone and ...

What is the current status of trial NCT02607033?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2015-10-01. Estimated completion is 2023-02-01.

What conditions does trial NCT02607033 study?

This clinical trial studies the following conditions: Peripheral Arterial Disease.

What interventions are being tested in trial NCT02607033?

The interventions under investigation include: Exercise (OTHER), Weight Loss (OTHER).

Who is sponsoring clinical trial NCT02607033?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02607033 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Peripheral Arterial Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.